Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer | Full Text
c-Met Archives - Network of Cancer Research
BMS-794833 | 99.84%(HPLC) | In Stock | c-Met inhibitor
c-Met Archives - Network of Cancer Research
cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors | ACS Omega
MET targeting: time for a rematch | Oncogene
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities | Molecular Cancer | Full Text
C-Met - Wikipedia
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
Tyrosine Kinase Assay Kits | MBL Life Sience -ASIA-
C-Met - wikidoc
IJMS | Free Full-Text | HGF/c-MET Signaling in Melanocytes and Melanoma
What Is MET? - MET Crusaders
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer | PNAS
Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
Structural basis of the activation of c-MET receptor | Nature Communications
Frontiers | HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
Artificial human Met agonists based on macrocycle scaffolds | Nature Communications
MET met proto-oncogene (hepatocyte growth factor receptor)
Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
C-Met - Wikipedia
c-Met Monoclonal Antibody (3D4) (37-0100)
c-MET
Kimono Style: The John C. Weber Collection - The Metropolitan Museum of Art
Safety and Tolerability of c-MET Inhibitors in Cancer | SpringerLink
